AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹268 Cr | ₹250 Cr | ₹246 Cr | ₹230 Cr | ₹208 Cr |
What is the latest Total Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹268 Cr |
| Mar2024 | ₹250 Cr |
| Mar2023 | ₹246 Cr |
| Mar2022 | ₹230 Cr |
| Mar2021 | ₹208 Cr |
How is Total Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹268 Cr | 7.50 | |
| Mar2024 | ₹250 Cr | 1.54 | |
| Mar2023 | ₹246 Cr | 6.82 | |
| Mar2022 | ₹230 Cr | 10.72 | |
| Mar2021 | ₹208 Cr | - | |
Compare Total Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹218.5 Cr | 3.8% | 0.1% | -47% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 3.8% |
0.1% |
-47% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses